Assessment of the Risk of Human Salmonellosis Associated With the Consumption of Tree Nuts; Request for Comments, Scientific Data and Information; Extension of Comment Period, 61365-61366 [2013-24171]

Download as PDF tkelley on DSK3SPTVN1PROD with NOTICES Federal Register / Vol. 78, No. 192 / Thursday, October 3, 2013 / Notices identify the individual’s data access rights once within the ESRD system. This data collection is currently being accomplished under ‘‘Part B’’ of the QualityNet Identity Management System Account Form. Once the ESRD Application Access Form is approved, the QualityNet Identity Management System (QIMS) Account Form will be revised to remove Part B from the QIMS data collection. The ESRD Application Access Request Form will be a new form and will be assigned its own OMB Control number. The ESRD system accounts created using the current QIMS Account Form—Part B will not need to submit an ESRD Application Access Form for the creation of their account since that information was collected under Part B. The QIMS Account Registration and the ESRD Application Access Request forms are required for identity and security management of individuals accessing the Consolidated Renal Operations in a Web Enabled Network (CROWNWeb) system and the End Stage Renal Disease Quality Incentive Program (ESRD QIP) system. The CROWNWeb system is the system that is mandated for the Medicare and Medicaid Programs Conditions of Coverage for End-Stage Renal Disease Facilities, Final Rule published April 15, 2008. Form Number: CMS–10484 (OCN: 0938—NEW); Frequency: Annually; Affected Public: Business and other for-profits and not-for-profits; Number of Respondents: 27,000; Total Annual Responses: 27,000; Total Annual Hours: 6,750. (For policy questions regarding this collection contact Victoria Schlining at 410–786– 6878.) 2. Type of Information Collection Request: Reinstatement with change of a previously approved collection; Title of Information Collection: Home Health Conditions of Participation (CoP) and Supporting Regulations; Use: The information collection requirements contained in this request are part of the requirements classified as the conditions of participation (CoPs) which are based on criteria prescribed in law and are standards designed to ensure that each facility has properly trained staff to provide the appropriate safe physical environment for patients. These particular standards reflect comparable standards developed by industry organizations such as the Joint Commission on Accreditation of Healthcare Organizations, and the Community Health Accreditation Program. The primary users of this information will be state agency surveyors, the regional home health intermediaries, CMS and home health VerDate Mar<15>2010 18:29 Oct 02, 2013 Jkt 232001 agencies (HHAs) for the purpose of ensuring compliance with Medicare CoPs as well as ensuring the quality of care provided by HHA patients. Form Numbers: CMS–R–39 (OCN: 0938– 0365); Frequency: Occasionally; Affected Public: Business or for-profits, Not-for-profit institutions, and State, Local or Tribal governments; Number of Respondents: 13,577; Total Annual Responses: 20,202,576; Total Annual Hours: 6,422,694. (For policy questions regarding this collection contact Danielle Shearer at 410–786–6617.) 3. Type of Information Collection Request: New collection (Request for a new OMB control number); Title of Information Collection: Medicare Prior Authorization of Power Mobility Devices (PMDs) Demonstration; Use: The purpose of the Medicare Prior Authorization of Power Mobility Devices Demonstration (the Demonstration) is to ensure that payments for PMDs are appropriate before the claims are paid, thereby preventing the fraud, waste, and abuse in the seven states participating in the Demonstration: California, Florida, Illinois, Michigan, New York, North Carolina and Texas. Additional benefits of the Demonstration include ensuring that a beneficiary’s medical condition warrants their medical equipment under existing coverage guidelines and preserving their ability to receive quality products from accredited suppliers. In order to gather qualitative information for analysis, the evaluation team will use semi-structured interview guides that focus on the direct impact of the Demonstration on stakeholder groups. Stakeholders will be drawn from advocacy organizations, power mobility device supply companies, state and local government, and healthcare practitioners. This information collection request explains the research methodology and data collection strategies designed to minimize the burden placed on research participants, while effectively gathering the data needed for the evaluation of the Demonstration. Form Number: CMS– 10471 (OCN: 0938—NEW); Frequency: Yearly; Affected Public: Private sector (business or other for-profit and not-forprofit institutions) and State and Local Governments; Number of Respondents: 281; Total Annual Responses: 281; Total Annual Hours: 317. (For policy questions regarding this collection contact Andrea Glasgow at 410–786– 4695. For all other issues call 410–786– 1326.) PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 61365 Dated: September 26, 2013. Martique Jones, Deputy Director, Regulations Development Group, Office of Strategic Operations and Regulatory Affairs. [FR Doc. 2013–24033 Filed 10–2–13; 8:45 am] BILLING CODE 4120–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2013–N–0747] Assessment of the Risk of Human Salmonellosis Associated With the Consumption of Tree Nuts; Request for Comments, Scientific Data and Information; Extension of Comment Period AGENCY: Food and Drug Administration, HHS. ACTION: Notice; extension of comment period. The Food and Drug Administration (FDA or we) is extending the comment period for the notice entitled ‘‘Assessment of the Risk of Human Salmonellosis Associated With the Consumption of Tree Nuts; Request for Comments, Scientific Data and Information’’ that appeared in the Federal Register of July 18, 2013 (78 FR 42963). In the notice, FDA requested comments and data relevant to conducting an assessment of the risk of human salmonellosis associated with the consumption of tree nuts. We are taking this action in response to requests for an extension to allow interested persons additional time to submit comments, scientific data, and information. SUMMARY: We are extending the comment period on the notice. Submit either electronic or written comments and scientific data and information by December 16, 2013. ADDRESSES: Submit electronic comments and scientific data and information to https:// www.regulations.gov. Submit written comments and scientific data and information to the Division of Dockets Management (HFA–305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. FOR FURTHER INFORMATION CONTACT: Sherri Dennis, Center for Food Safety and Applied Nutrition (HFS–06), Food and Drug Administration, 5100 Paint Branch Pkwy., College Park, MD 20740, 240–402–1914. SUPPLEMENTARY INFORMATION: DATES: E:\FR\FM\03OCN1.SGM 03OCN1 61366 Federal Register / Vol. 78, No. 192 / Thursday, October 3, 2013 / Notices I. Background In the Federal Register of July 18, 2013 (78 FR 42963), we published a notice entitled ‘‘Assessment of the Risk of Human Salmonellosis Associated With the Consumption of Tree Nuts; Request for Comments, Scientific Data and Information.’’ The notice provided a 90-day comment period for comments, scientific data, and information relevant to conducting an assessment of the risk of human salmonellosis associated with the consumption of tree nuts. We have received three requests for an extension of the comment period for the notice. Each request conveyed concern that the current 90-day comment period is not adequate to develop a response to the notice. We have considered these requests and are extending the comment period for the notice for 60 days, until December 16, 2013. We believe that a 60-day extension allows adequate time for interested persons to submit comments, scientific data, and information without significantly delaying the risk assessment. II. Comments Interested persons may submit either electronic comments and scientific data and information to https:// www.regulations.gov or written comments and scientific data and information to the Division of Dockets Management (see ADDRESSES). It is only necessary to send one set of comments. Identify comments with the docket number found in brackets in the heading of this document. Received comments may be seen in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday, and will be posted to the docket at https:// www.regulations.gov. Dated: September 27, 2013. Leslie Kux, Assistant Commissioner for Policy. [FR Doc. 2013–24171 Filed 10–2–13; 8:45 am] BILLING CODE 4160–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES tkelley on DSK3SPTVN1PROD with NOTICES Health Resources and Services Administration Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request Health Resources and Services Administration, HHS. AGENCY: VerDate Mar<15>2010 18:29 Oct 02, 2013 Jkt 232001 ACTION: Notice. In compliance with Section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the Health Resources and Services Administration (HRSA) has submitted an Information Collection Request (ICR) to the Office of Management and Budget (OMB) for review and approval. Comments submitted during the first public review of this ICR will be provided to OMB. OMB will accept further comments from the public during the review and approval period. DATES: Comments on this ICR should be received within 30 days of this notice. ADDRESSES: Submit your comments, including the Information Collection Request Title, to the desk officer for HRSA, either by email to OIRA_ submission@omb.eop.gov or by fax to 202–395–5806. FOR FURTHER INFORMATION CONTACT: To request a copy of the clearance requests submitted to OMB for review, email the HRSA Information Collection Clearance Officer at paperwork@hrsa.gov or call (301) 443–1984. SUPPLEMENTARY INFORMATION: Information Collection Request Title: Nurse Anesthetist Traineeship (NAT) Program Application OMB No. 0915–xxxx—NEW. Abstract: The Health Resources and Services Administration (HRSA) provides advanced education nursing training grants to educational institutions to increase the numbers of Nurse Anesthetists through the NAT Program. The NAT Program is governed by Title VIII, Section 811(a)(2) of the Public Health Service Act, (42 U.S.C. 296j(a)(2)), as amended by Section 5308 of the Patient Protection and Affordable Care Act, Public Law 111–148. The NAT application will use the SF–424 R &R Short Form which includes the Project Abstract, Program Narrative, NAT Attachments, and the NAT Tables. The application and proposed NAT Tables will request information on program participants such as the number of enrollees, number of enrollees/trainees supported, number of graduates, number of graduates supported, projected data on enrollees/trainees and graduates for the previous fiscal year, the types of programs they are enrolling into and/or from which enrollees/ trainees are graduating, and the distribution of Nurse Anesthetists to practice in underserved, rural, or public health practice settings. SUMMARY: PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 Need and Proposed Use of the Information: Funds appropriated for the NAT Program are distributed among eligible institutions based on a formula. NAT award amounts are based on enrollment and graduate data and two funding factors (Statutory Funding Preference and Special Consideration) reported on the NAT Tables. HRSA will use the data from the application, specifically the NAT Tables, to determine the award, ensure programmatic compliance, and provide information to the public and Congress. Likely Respondents: Eligible applicants are collegiate schools of nursing, nursing centers, academic health centers, state or local governments, and other public or private nonprofit entities determined appropriate by the Secretary that submit an application and are accredited for the provision of nurse anesthesia educational program by designated accrediting organizations. Eligible applicants must be accredited by the Council on Accreditation (COA) of Nurse Anesthesia Educational Programs of the American Association of Nurse Anesthetists. The school must be located in the 50 states, the District of Columbia, the Commonwealth of Puerto Rico, the Northern Mariana Islands, American Samoa, Guam, the U.S. Virgin Islands, the Federated States of Micronesia, the Republic of the Marshall Islands, or the Republic of Palau. Burden Statement: Burden in this context means the time expended by persons to generate, maintain, retain, disclose or provide the information requested. This includes the time needed to review instructions; to develop, acquire, install and utilize technology and systems for the purpose of collecting, validating and verifying information, processing and maintaining information, and disclosing and providing information; to train personnel and to be able to respond to a collection of information; to search data sources; to complete and review the collection of information; and to transmit or otherwise disclose the information. The total annual burden hours estimated for this ICR are summarized in the table below. E:\FR\FM\03OCN1.SGM 03OCN1

Agencies

[Federal Register Volume 78, Number 192 (Thursday, October 3, 2013)]
[Notices]
[Pages 61365-61366]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-24171]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2013-N-0747]


Assessment of the Risk of Human Salmonellosis Associated With the 
Consumption of Tree Nuts; Request for Comments, Scientific Data and 
Information; Extension of Comment Period

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; extension of comment period.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or we) is extending the 
comment period for the notice entitled ``Assessment of the Risk of 
Human Salmonellosis Associated With the Consumption of Tree Nuts; 
Request for Comments, Scientific Data and Information'' that appeared 
in the Federal Register of July 18, 2013 (78 FR 42963). In the notice, 
FDA requested comments and data relevant to conducting an assessment of 
the risk of human salmonellosis associated with the consumption of tree 
nuts. We are taking this action in response to requests for an 
extension to allow interested persons additional time to submit 
comments, scientific data, and information.

DATES: We are extending the comment period on the notice. Submit either 
electronic or written comments and scientific data and information by 
December 16, 2013.

ADDRESSES: Submit electronic comments and scientific data and 
information to https://www.regulations.gov. Submit written comments and 
scientific data and information to the Division of Dockets Management 
(HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, 
Rockville, MD 20852.

FOR FURTHER INFORMATION CONTACT: Sherri Dennis, Center for Food Safety 
and Applied Nutrition (HFS-06), Food and Drug Administration, 5100 
Paint Branch Pkwy., College Park, MD 20740, 240-402-1914.

SUPPLEMENTARY INFORMATION: 

[[Page 61366]]

I. Background

    In the Federal Register of July 18, 2013 (78 FR 42963), we 
published a notice entitled ``Assessment of the Risk of Human 
Salmonellosis Associated With the Consumption of Tree Nuts; Request for 
Comments, Scientific Data and Information.'' The notice provided a 90-
day comment period for comments, scientific data, and information 
relevant to conducting an assessment of the risk of human salmonellosis 
associated with the consumption of tree nuts.
    We have received three requests for an extension of the comment 
period for the notice. Each request conveyed concern that the current 
90-day comment period is not adequate to develop a response to the 
notice.
    We have considered these requests and are extending the comment 
period for the notice for 60 days, until December 16, 2013. We believe 
that a 60-day extension allows adequate time for interested persons to 
submit comments, scientific data, and information without significantly 
delaying the risk assessment.

II. Comments

    Interested persons may submit either electronic comments and 
scientific data and information to https://www.regulations.gov or 
written comments and scientific data and information to the Division of 
Dockets Management (see ADDRESSES). It is only necessary to send one 
set of comments. Identify comments with the docket number found in 
brackets in the heading of this document. Received comments may be seen 
in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday 
through Friday, and will be posted to the docket at https://www.regulations.gov.

    Dated: September 27, 2013.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2013-24171 Filed 10-2-13; 8:45 am]
BILLING CODE 4160-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.